ta 0910 has been researched along with methoxyhydroxyphenylglycol in 1 studies
| Studies (ta 0910) | Trials (ta 0910) | Recent Studies (post-2010) (ta 0910) | Studies (methoxyhydroxyphenylglycol) | Trials (methoxyhydroxyphenylglycol) | Recent Studies (post-2010) (methoxyhydroxyphenylglycol) |
|---|---|---|---|---|---|
| 64 | 2 | 14 | 3,297 | 275 | 282 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahi, T; Fukuchi, I; Kawashima, K; Kawashima, Y; Kinoshita, K; Matsuoka, Y; Yamamura, M | 1 |
1 other study(ies) available for ta 0910 and methoxyhydroxyphenylglycol
| Article | Year |
|---|---|
Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Thyrotropin-Releasing Hormone | 1998 |